Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone for chronic post-stroke aphasia: multicentre, randomised controlled trial.

The BMJ Pub Date : 2025-06-25 DOI:10.1136/bmj-2024-083605
Juntao Feng,Ruiping Hu,Minzhi Lyu,Xingyi Ma,Tie Li,Yuan Meng,Wenjun Qi,Haozheng Li,Ying Zhang,Shanshan Ding,Zhiyu Wang,Xiu'En Chen,Jiejiao Zheng,Yongqian Fan,Ling Ding,Lihui Wang,Zilong Wei,Xiaozhi Zhu,Mingxuan Guo,Kaixiang Yang,Wenshuo Chang,Jingrui Yang,Miaomiao Xu,Wen Fang,Ying Liu,Yanqun Qiu,Huawei Yin,Jie Jia,Yundong Shen,Yizheng Wang,Yudong Gu,Wendong Xu
{"title":"Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone for chronic post-stroke aphasia: multicentre, randomised controlled trial.","authors":"Juntao Feng,Ruiping Hu,Minzhi Lyu,Xingyi Ma,Tie Li,Yuan Meng,Wenjun Qi,Haozheng Li,Ying Zhang,Shanshan Ding,Zhiyu Wang,Xiu'En Chen,Jiejiao Zheng,Yongqian Fan,Ling Ding,Lihui Wang,Zilong Wei,Xiaozhi Zhu,Mingxuan Guo,Kaixiang Yang,Wenshuo Chang,Jingrui Yang,Miaomiao Xu,Wen Fang,Ying Liu,Yanqun Qiu,Huawei Yin,Jie Jia,Yundong Shen,Yizheng Wang,Yudong Gu,Wendong Xu","doi":"10.1136/bmj-2024-083605","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nTo evaluate whether right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy (SLT) improves language function compared intensive SLT alone in patients with chronic aphasia after stroke.\r\n\r\nDESIGN\r\nMulticentre, assessor blinded, randomised controlled trial.\r\n\r\nSETTING\r\nFour centres in mainland China.\r\n\r\nPARTICIPANTS\r\n50 adults aged 40-65 years with aphasia for more than one year after a single left hemispheric stroke.\r\n\r\nINTERVENTIONS\r\nParticipants were randomised 1:1 to receive either C7 neurotomy plus three weeks of intensive SLT or three weeks of intensive SLT only, stratified by treatment centre.\r\n\r\nMAIN OUTCOME MEASURES\r\nThe primary outcome was change in score on the 60 item Boston naming test (BNT, scores 0-60, with higher scores indicating better naming function) from baseline to one week after C7 neurotomy plus intensive SLT for three weeks or intensive SLT for three weeks after deferral for one week (control group). Secondary outcomes included change in severity of aphasia using the aphasia quotient, calculated using the western aphasia battery, and patient reported outcomes on quality of life and depression after stroke.\r\n\r\nRESULTS\r\nFrom 25 July 2022 to 31 July 2023, 322 out of 1086 patients received a diagnosis of post-stroke aphasia and were screened for eligibility. 50 eligible participants were randomly assigned to treatment groups (25 in each). Mean increase in BNT score was 11.16 points in the neurotomy plus SLT group and 2.72 points in the control group at one month (difference 8.51 points, 95% confidence interval (CI) 5.31 to 11.71, P<0.001). The between group difference in BNT score remained stable at six months (difference 8.26 points, 4.16 to 12.35, P<0.001). In addition, the aphasia quotient improved significantly in the neurotomy plus SLT group versus control group (difference at one month 7.06 points, 4.41 to 9.72, P<0.001), as did patient reported activities of daily living and post-stroke depression. No treatment related severe adverse events were reported.\r\n\r\nCONCLUSIONS\r\nC7 neurotomy plus three weeks of intensive SLT was associated with a greater improvement in language function compared with three weeks of intensive SLT alone over a period of six months. No severe adverse events or long term troublesome symptoms or functional loss were reported.\r\n\r\nTRIAL REGISTRATION\r\nChinese Clinical Trial Register ChiCTR2200057180.","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"67 2 1","pages":"e083605"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj-2024-083605","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVE To evaluate whether right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy (SLT) improves language function compared intensive SLT alone in patients with chronic aphasia after stroke. DESIGN Multicentre, assessor blinded, randomised controlled trial. SETTING Four centres in mainland China. PARTICIPANTS 50 adults aged 40-65 years with aphasia for more than one year after a single left hemispheric stroke. INTERVENTIONS Participants were randomised 1:1 to receive either C7 neurotomy plus three weeks of intensive SLT or three weeks of intensive SLT only, stratified by treatment centre. MAIN OUTCOME MEASURES The primary outcome was change in score on the 60 item Boston naming test (BNT, scores 0-60, with higher scores indicating better naming function) from baseline to one week after C7 neurotomy plus intensive SLT for three weeks or intensive SLT for three weeks after deferral for one week (control group). Secondary outcomes included change in severity of aphasia using the aphasia quotient, calculated using the western aphasia battery, and patient reported outcomes on quality of life and depression after stroke. RESULTS From 25 July 2022 to 31 July 2023, 322 out of 1086 patients received a diagnosis of post-stroke aphasia and were screened for eligibility. 50 eligible participants were randomly assigned to treatment groups (25 in each). Mean increase in BNT score was 11.16 points in the neurotomy plus SLT group and 2.72 points in the control group at one month (difference 8.51 points, 95% confidence interval (CI) 5.31 to 11.71, P<0.001). The between group difference in BNT score remained stable at six months (difference 8.26 points, 4.16 to 12.35, P<0.001). In addition, the aphasia quotient improved significantly in the neurotomy plus SLT group versus control group (difference at one month 7.06 points, 4.41 to 9.72, P<0.001), as did patient reported activities of daily living and post-stroke depression. No treatment related severe adverse events were reported. CONCLUSIONS C7 neurotomy plus three weeks of intensive SLT was associated with a greater improvement in language function compared with three weeks of intensive SLT alone over a period of six months. No severe adverse events or long term troublesome symptoms or functional loss were reported. TRIAL REGISTRATION Chinese Clinical Trial Register ChiCTR2200057180.
椎间孔右侧C7神经切开术加强化言语和语言治疗与单独强化言语和语言治疗治疗脑卒中后慢性失语症:多中心随机对照试验
目的评价脑卒中后慢性失语症患者椎间孔第七颈神经(C7)右侧神经切断术加强化语言治疗(SLT)与单纯强化语言治疗(SLT)相比是否能改善语言功能。设计多中心、评估者盲法、随机对照试验。在中国大陆有四个中心。参与者50名年龄在40-65岁的成年人,在单次左半球中风后失语超过一年。干预措施:参与者按1:1随机分组,接受C7神经切断术加3周强化SLT或仅接受3周强化SLT,按治疗中心分层。主要结局指标:主要结局是C7神经切断术加强化SLT治疗3周后,基线至1周后(对照组)60项波士顿命名测验(BNT,评分0-60分,评分越高表明命名功能越好)评分的变化。次要结果包括使用失语商(使用西方失语电池计算)来改变失语的严重程度,以及患者报告的中风后生活质量和抑郁的结果。结果从2022年7月25日至2023年7月31日,1086名患者中有322名接受了卒中后失语症的诊断,并进行了资格筛选。50名符合条件的参与者被随机分配到治疗组(每组25人)。1个月时,神经切开术加SLT组BNT评分平均增加11.16分,对照组平均增加2.72分(差异8.51分,95%可信区间(CI) 5.31 ~ 11.71, P<0.001)。组间BNT评分差异在6个月时保持稳定(差异8.26分,4.16 ~ 12.35分,P<0.001)。此外,与对照组相比,神经切开术加SLT组的失语商显著改善(1个月时差异为7.06分,4.41分至9.72分,P<0.001),患者报告的日常生活活动和卒中后抑郁也有显著改善。治疗相关的严重不良事件未见报道。结论:在6个月的时间里,sc7神经切断术加3周强化SLT与单独进行3周强化SLT相比,语言功能的改善更大。没有严重的不良事件或长期麻烦的症状或功能丧失的报告。中国临床试验注册中心ChiCTR2200057180。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信